C7A.098 — Malignant carcinoid tumors of other sites
Is C7A.098 billable?
Yes — C7A.098 is billable for FY2027. C7A.098 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C7A.098 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C7A.098 at a glance
| Code | C7A.098 |
|---|---|
| Description | Malignant carcinoid tumors of other sites |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C7A.098 group to?
C7A.098 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCsurgical
- 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCsurgical
- 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCsurgical
As a secondary diagnosis, C7A.098 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.
How is C7A.098 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to C7A.098. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Tumor › carcinoid › malignant › specified NEC
Use additional code — inherited from C7A
Report an additional code alongside C7A.098 to fully describe the condition. C7A.098 is sequenced first.
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.00)
Excludes2 — not included here — inherited from C7A
The conditions below are not part of C7A.098, but a patient may have both at the same time. When documentation supports it, C7A.098 and the excluded code may both be reported.
Code also — inherited from C7A
Two codes may be needed to describe the condition fully. Whether C7A.098 is sequenced first depends on the reason for the encounter.
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
How long has C7A.098 existed?
C7A.098 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.
What other codes are in the C7A.09 family? (7)
- C7A.090Malignant carcinoid tumor of the bronchus and lung
- C7A.091Malignant carcinoid tumor of the thymus
- C7A.092Malignant carcinoid tumor of the stomach
- C7A.093Malignant carcinoid tumor of the kidney
- C7A.094Malignant carcinoid tumor of the foregut, unspecified
- C7A.095Malignant carcinoid tumor of the midgut, unspecified
- C7A.096Malignant carcinoid tumor of the hindgut, unspecified